Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucrose dosing for neonatal procedural pain
NCT06446323Completed
- Sponsor
- Rawalpindi Medical University
- Start
- Mar 2023
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial of Sucrose in procedural pain (2 arms), sponsored by Rawalpindi Medical University. Primary endpoint: Premature Infant Pain Profile. Started Mar 2023; status: completed.
02
Drugs
Sucrose
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06446323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446323.